SlideShare une entreprise Scribd logo
1  sur  28
Wessanen 2012 overview
                      Revenue                            EBIT before exceptionals




                 129                                               6,3

                                       273

                   €711mln                               1,8         €19mln*
           113                                           0,0

                                                                                   22,0
                           *
                       205


           Grocery HFS IZICO           ABC                Grocery HFS IZICO            ABC
         * Incl. intercompany sales                     * Incl. non-allocated

                 FTEs (average)                          Average Capital Employed



                        62                                                 7
                                 434
                451                                            48
                                                                                       89

                      2,064                                         €240mln
                                                              37
                487                   630

                                                                            59

      Grocery   HFS    IZICO    ABC     Corporate                                                  1
                                                    Grocery    HFS       IZICO   ABC   Corporate
Royal Wessanen nv

              Q4/FY 2012

Amsterdam, 22 February 2013




                       www.wessanen.com
FY 2012: a challenging year
                                                            730
                                                                               Revenue (in € mln)
The economy and market
A turbulent year for the global economy
Organic market trending positively                         720



Our positives
Grocery continues to perform well
                                                            710
Acquisition of Clipper Teas
Creation of one frozen food company
                                                                                        0.7%
Strengthening Supervisory Board
                                                            700
                                                                  2011   Price/mix   Volume    Currency   Acq/divest.   2012
Our negatives
Performance HFS disappointing                                ♦ Autonomous third party revenue growth
Postponement sale of ABC
                                                                                EBIT (in € mln)
Sizeable goodwill impairments

Our remedy                                                                   23,7                             18,8
Initiated a broad restructuring to build a more European
                                                                     -19,0
integrated marketing-led company                                                                   -45,8




                                                                         2011                             2012


                                                              ♦ Reported, ♦ Normalised
                                                                                                                           3
Grocery
    Showing a good performance all throughout the year
                                                                         In € mln             Q4-12    Q4-11
    Realised 4.6% autonomous growth in 2012
                                                                         Revenue              68.9     58.7
       6.9% in the fourth quarter
                                                                         Autonomous growth    6.9%
    Core brands growing such as Bjorg, Zonnatura and Whole Earth
                                                                         Normalised EBIT       6.3      1.9

    Six out of eight core categories growing                            Impairments          (15.8)   (3.0)

                                                                         Other exceptionals   (3.5)    (0.5)
    Clipper Teas acquired, UK market leader in organic and fair trade
     teas                                                                EBIT                 (13.0)   (1.6)
        11% growth in 2012
        In France introduced early 2013
        Netherlands to follow next few months                           In € mln             FY12     FY11

                                                                         Revenue              272.8    243.9
    Innovation examples:
       Bjorg muesli superfruits; coconut milk cooking aid; fourré       Autonomous growth     4.6%
        chocolat with hazelnut
                                                                         Normalised EBIT       22.0    18.0
       Zonnatura loose green tea; squeeze fruit/vegetables
       Kallo gravy granules                                             Impairments          (15.8)   (3.0)

                                                                         Other exceptionals    (4.7)    0.6

                                                                         EBIT                   1.5    15.6


                                                                                                          4
Health Food Stores (HFS)
    HFS showing a disappointing performance in all three businesses
                                                                        In € mln             Q4-12     Q4-11
    France impacted by changing health food stores landscape
                                                                        Revenue               50.9     53.3
     Rise of chains at expense independent stores
     Lower sales, especially in wholesale and at fresh                 Autonomous growth    (4.5)%

                                                                        Normalised EBIT       0.8       1.3
    Benelux impacted by lost customers and weak performance at Fresh
     Existing Natuurwinkel and independent stores growing              Impairments          (23.9)    (19.8)

                                                                        Other exceptionals   (6.5)     (1.0)
    Germany impacted by weak brand performance Allos and declining
     revenues at Reformhaus channel (Tartex)                            EBIT                 (29.6)    (19.5)


    Innovation examples:
     Tartex pasta sauces; jubilee yeast pastries                       In € mln              FY12      FY11
     Allos crunchy (e.g. almond and cinnamon); muesli (e.g.
                                                                        Revenue               204.8     247.5
        cranberry-Goji)
                                                                        Autonomous growth    (5.0)%

                                                                        Normalised EBIT         -        5.0

                                                                        Impairments           (23.9)   (23.1)

                                                                        Other exceptionals    (6.5)     (3.7)

                                                                        EBIT                  (30.4)   (21.8)


                                                                                                          5
IZICO - integrated frozen foods company
    Acquiring non-controlling stake Favory paved the way for creation one
     integrated company                                                      In € mln             Q4-12     Q4-11

                                                                             Revenue               29.0     29.1
    New management team in place
                                                                             Autonomous growth    (0.1)%
    New name IZICO
                                                                             Normalised EBIT       0.7       0.2
     easy (IZI), go (CO), ice (IZ) and company (CO)
                                                                             Impairments          (7.0)     (14.3)
       Milestone plan being executed for full alignment and process
                                                                             Other exceptionals   (6.2)     (0.3)
        integration Beckers Benelux and Favory
                                                                             EBIT                 (12.5)    (14.4)
    Combining both headquarters in Breda
     Integration marketing & sales, operations, finance and HR
                                                                             In € mln              FY12      FY11
    Closure Favory Deurne plant as of the end of March
                                                                             Revenue               112.5     113.1

                                                                             Autonomous growth     (0.5)%

                                                                             Normalised EBIT        1.8       2.3

                                                                             Impairments           (7.0)    (14.3)

                                                                             Other exceptionals    (6.2)     (0.3)

                                                                             EBIT                  (11.4)   (12.3)


                                                                                                               6
ABC - market leader RTD frozen pouches
    Capitalising on further optimisation in 2011 after significant
                                                                      In € mln             Q4-12    Q4-11
     improvement multiple processes in previous years
                                                                      Revenue               16.9    18.0
    Strong step-up in marketing spending in $-terms
       Supporting key seasonal holidays                              Autonomous growth    (4.7)%

       First-ever national TV advertising campaign                   Normalised EBIT      (3.0)    (0.5)
       Broad range traditional and digital media
                                                                      Impairments            -       0.1

    Daily’s modest decline in growing RTD market                     Other exceptionals     -       0.1
      More competition emerged in frozen pouch segment
      Remained clear market leader (market share; household          EBIT                 (3.0)    (0.3)

       penetration; repeat purchases)

    Innovations such as light and season-extending RTD pouches       In € mln              FY12    FY11

                                                                      Revenue               128.6   112.6
    Little Hug double digits revenue growth
       Especially 20-pack and 40-pack performing well                Autonomous growth     5.7%

       Multi-year revitalisation process increasingly paying off     Normalised EBIT        6.3     9.9

                                                                      Impairments           (0.1)    0.8

                                                                      Other exceptionals     0.1     0.4

                                                                      EBIT                   6.3    11.1


                                                                                                       7
ABC (cont’d)
    Why postponement divestment ?!
     Bids not adequately reflecting fundamental value
     •   Uncertainties attached to relatively short track record in emerging RTD frozen
         pouch category; perceived to be crowded competitive field
     Realise better value for our shareholders at a later stage

    The process
     Process kicked off in June
     Conducted a comprehensive process
     Good level of interest from strategic and financial parties

    Next steps
     Reported as ‘continuing operations’
     Clear plans / budgets in place
     Labelled non-core




                                                                                          8
‘Wessanen 2015’
    Announced late November 2012

    Consultation with European and local works councils have been / are taking place

    Wessanen will become a more consumer- and customer-led company

    To deliver more efficiently our strategic agenda and to adapt to the changed magnitude and
     circumstances of the business

    We have been initiating wide range of actions
      To increase focus
      To substantially reduce complexity
      To become more profitable by reducing costs

    Detailed plan and timeline with numerous actions at our various businesses
       Progress (including savings and staff reduction) closely monitored
       Executing plans in various ‘waves’, to reduce executional risks




                                                                                                  9
‘Wessanen 2015’ - the numbers
    Reduction of approx. 300 FTE of which 250 forced redundancies
      Grocery/HFS/Corporate ± 190FTE
      IZICO ± 110 FTE

    Expected one-off costs
       €(21) mln cash, largely accounted for in Q4, remainder in 2013
       €(7.0) mln non-cash due to impairment Deurne plant

    Expected savings €15mln p.a. from 2014 onwards
       €10 mln at Grocery/HFS/Corporate
       € 5mln at IZICO

       Includes lower employee / other operating expenses
       Excludes any expected benefits to top-line




                                                                         10
‘Wessanen 2015’ - a wide range of actions
 Create more focus on our activities
    Further increased focus on core brands and eight core categories
    Expansion number of CBTs (category brand teams)
    Benelux operations split in branded and distribution
    French HFS operations split in branded and distribution
    Integration De Rit in Germany operations

 Reduce complexity / simplify processes
   Cutting the tail / reducing number of SKUs at
    •   Dutch brands
    •   French HFS brands; exiting frozen range at Bonneterre
    •   Export
   Centralising quality department
   Focus on one franchise formula (Natuurwinkel), to end GooodyFooods formula
   Supply chain to manage our plants as of 2013
   Streamlining supply chain processes

 Addressing low-yielding and non-performing activities
   Strongly reducing German grocery presence, changing go-to-market approach
   Focus Italian grocery on non-dairy (soy)




                                                                                 11
Ronald Merckx (CFO)

• Q4/FY financials




                      12
Q4/FY key figures
 In € million                                 Q4-12    Q4-11    FY-12    FY-11

Revenue                                       163.8    157.2    710.8    706.0

Autonomous growth                              0.7%              0.7%

Gross contribution                            60.9     60.5     270.5    263.6

As % of revenue                               37.2%    38.5%    38.1%    37.3%


Normalised EBIT                                1.9     (1.3)    18.8     23.7

As % of revenue                                1.1%    (0.8)%    2.6%    3.4%


EBIT                                          (61.6)   (39.9)   (45.8)   (19.0)

Net result ¹                                  (61.5)   (35.1)   (53.2)   (17.1)

Earnings per share (EPS)                      (0.81)   (0.46)   (0.70)   (0.23)




                                                                                  13
  ¹ Attributable to Wessanen equity holders
EBIT - from normalised to reported

                          Q4-12    Q4-11    FY-12    FY-11

Normalised EBIT            1.9     (1.3)    18.8     23.7

Impairments               (46.7)   (37.0)   (46.8)   (39.6)

Wessanen 2015             (16.3)     -      (16.6)     -

Other exceptional costs   (0.5)    (1.6)    (1.2)    (3.1)

EBIT                      (61.6)   (39.9)   (45.8)   (19.0)




                                                              14
Impairments of goodwill and PPE
    Grocery UK - Kallo          €(15.8) mln
     Lower growth projections dairy alternatives, loss private label contract, adverse
       movement pre-tax discount rate (12.1%→12.7%)

    HFS - Tartex                 €(19.9) mln
     Lower growth projections Reformhaus channel
     Private label business negatively impacted by insolvency one of our customers

    HFS - Allos                    €(3.5) mln
     Lower growth projections 2 core categories
     Difficulties in passing on increased raw material costs

    HFS - France                        €(0.5) mln *
     Weaker market outlook

    IZICO                       €(7.0) mln
     Closure of Favory Deurne plant in March 2013




* €(0.3) mln relates to goodwill and €(0.2) mln relates to other intangibles
                                                                                          15
Year end carrying value goodwill/brands

 In € mln                                          Goodwill        Brands         Total

 Grocery - France                                     10.4           9.1          19.5

 Grocery - UK (Kallo / Clipper)                       11.1          10.5          21.6

 Grocery - Benelux                                    4.6             -            4.6

 HFS - Allos                                          9.3            2.1          11.4

 HFS - Tartex                                          -             1.2           1.2

 Carrying value year end 2012                         35.4          22.9          58.3




At year end 2012: no carrying value of goodwill and/or brands at Grocery Italy, Grocery Germany,
HFS France, HFS Benelux, IZICO and ABC
                                                                                                   16
Cash flow 2012
              22.2    (42.3)


                               Increase working
                       (7.6)
                                    capital



Cash flow
  from        22.2
earnings




                      (26.1)
            Sources
                                Net Investments
                                      (*)




                                                           Increase
                                                    20.1     of net
                                                           debt (**)

                       (6.1)   Dividends paid




                       (2.5)   Derivatives and FX


                                         Uses
                                                                       17
Net debt / Leverage ratio
 In € mln
 100
                                                                             Net debt
   75
                                                                             €55 mln

   50




   25




    0
            Q4 10   Q1 11   Q2 11   Q3 11   Q4 11   Q1 12   Q2 12   Q3 12      Q4 12




    3

                                                                    Leverage ratio
                                                                                1.7x
    2




    1




    0
        Q4 10       Q1 11   Q2 11   Q3 11   Q4 11   Q1 12   Q2 12    Q3 12     Q4 12

                                                                                        18
Piet Hein Merckens (CEO)

• Closing remarks




                           19
Looking forward
    2012 was a turbulent year for the global economy

    Organic food markets continue to trend positively

    We have made clear progress in numerous areas, however not all initiatives have resulted in
     desired outcome

    We have run a connected leadership development programme for our top-60

    We have initiated a comprehensive transformation programme
      As of 2014 €15 mln of savings p.a.

    All the right actions, full of confidence these will bear fruit

    2013 will be another challenging year: “Store is open while we are renovating and innovating”




                                                                                                     20
Appendices




             21
Bridge - revenue growth 2012

In € mln
  730
                       (2.1).%            2.8%           1.8%            (4.2)%          (0.2)%          2.6%        0.7%


  720


  710


  700


  690
                            Autonomous
                           revenue growth
  680
                                  0.7%

  670
                                                                     ts
                                         ix
                      e




                                                                                    r




                                                                                                        r
                                                        cy
           1




                                                                                                                    2
                                                                                     e




                                                                                                    pe
                   m




                                                                     n
           1




                                                                                                                 1
                                   /m




                                                                                   th
                                                      en




                                                                     e




                                                                                                                0
         0




                  u




                                                                                                   p
                                                                   tm
        2




                                                                                                                2
                                                                                  O
               ol




                                                                                                   li
                                  ce




                                                  rr




                                                                                                  C
               V




                                                                 es
                                                  u
                                  ri




                                                 C
                                 P




                                                                iv
                                                             D




                                                                                                                        22
Bridge: EBITE → EBIT

In € mln
  30


  20


  10
                                                                                                                          €(46.8)       €(45.8)


   0




                                                                                                                         ts
                                                                                                         s
                                                                                          E
                                                                                e
                        y




                                                O




                                                               C
                                    FS
           1




                                                                                                                                        2
                                                                                                       al
                                                                                        IT
                                                                              t
                        r




                                                                                                                         en
                                                               B




                                                                                                                                    01
       01




                                                IC




                                                                           ra
                      ce




                                                                                                      on
                                   H




                                                              A




                                                                                       EB
                                              IZ




                                                                                                                       rm
                                                                           po
       2




                                                                                                                                    2
 -10
                    ro




                                                                                                    ti
                                                                        or
                    G




                                                                                                   p




                                                                                                                     ai
                                                                                                 ce




                                                                                                                p
                                                                    C




                                                                                                              Im
                                                                                              Ex
 -20
            €23.7           €4.0     €(5.0)          €(0.5)    €(3.6)           €0.2        €18.8          €(17.8)

 -30


 -40


 -50
                                                                                                                                            23
Working capital
 80
                              4 quarter average working capital

 60




 40




 20




  0
      Q4 08   Q2 09   Q4 09    Q2 10     Q4 10      Q2 11     Q4 11   Q2 12   Q4 12


40
                               q-on-q movement working capital

20




 0




-20




-40
      Q4 08   Q2 09   Q4 09   Q2 10      Q4 10      Q2 11     Q4 11   Q2 12   Q4 12   24
Cash flow Q4 2012


              3.7     (2.1)

Decrease
working       1.6     (1.6)   Net Investments
capital
                              Derivatives and
                      (0.5)
                              FX




              2.1                                       Decrease
                                                (1.6)    of net
Cash flow                                                 debt
from
earnings




            Sources               Uses


                                                                   25
A very sound financial position
 In € mln                         Dec 12   Dec 11    In € mln                               Dec12   Dec11

Assets                                              Liabilities

Property, plant and equipment      77.4     86.4    Total equity                            101.6   166.1

Intangible assets                  66.8     90.6    Interest-bearing loans                  60.7    37.4

Investment associates/other        1.1      1.0     Employee benefits                       24.1    24.0

Deferred tax assets                9.2      8.8     Provisions / Deferred tax liabilities    5.4     3.9

Non-current assets                154.5    186.8    Non-current liabilities                 90.2    65.3




                                                    Bank overdrafts / current debt           1.4     2.9

Inventories                        72.3     67.5    Interest-bearing loans/borrowings        2.5     0.1

Income tax receivables              -       2.2     Provisions                              16.8     3.3

Trade receivables                  85.7     78.9    Income tax payables                      0.7     0.5

Other receivables / prepayments    15.7     24.4    Trade payables                          68.3    70.5

Cash (equivalents)                 9.7      8.2     Non-trade payables/accrued expenses     56.4    59.3

Current assets                    183.4    181.2    Current liabilities                     146.1   136.6

TOTAL ASSETS                      337.9    368.0    TOTAL EQUITY & LIABILITIES              337.9   368.0
                                                                                                            26
Financials Q4/FY - guidance 2013
Financials Q4
   Net financing costs €(1.1) mln        Q4-11: €(0.9) mln
   Income tax expenses €1.2 mln          Q4-11: €1.7 mln
   Capex €(1.2) mln                      Q4-11: €(3.3) mln


Financials Full Year
   Net financing costs €(3.8) mln        FY-11: €(3.5) mln
   Income tax expenses €(3.9) mln        FY-11: €1.5 mln
   Capex €(5.7) mln                      FY-11: €(10.2) mln


Guidance 2013
   Net financing costs €(3)-(4) mln
   Effective tax rate around 35%
   Capex €(8)-(10) mln
   Depreciation and amortisation €(14) mln
   Non-allocated expenses (incl. corporate) €(11) mln

                                                               27
Royal Wessanen nv

                  Q4 2011

Amsterdam, 23 February 2012

Contenu connexe

Tendances

GSK con ru1 qcy2010-230410
GSK con ru1 qcy2010-230410GSK con ru1 qcy2010-230410
GSK con ru1 qcy2010-230410Angel Broking
 
KF in brief 2004
KF in brief 2004KF in brief 2004
KF in brief 2004KF Online
 
Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference finance4
 
Billerud Interim Report Q1 2012 presentation
Billerud Interim Report Q1 2012 presentationBillerud Interim Report Q1 2012 presentation
Billerud Interim Report Q1 2012 presentationBillerudKorsnäs
 
Britvic company evaluation
Britvic company evaluationBritvic company evaluation
Britvic company evaluationjinsisi
 
Aventis Result Update
Aventis Result UpdateAventis Result Update
Aventis Result UpdateAngel Broking
 
BASF Capital Market Story 05/2012
BASF Capital Market Story  05/2012BASF Capital Market Story  05/2012
BASF Capital Market Story 05/2012BASF
 
Hero Honda Q4 Results Update
Hero Honda Q4 Results UpdateHero Honda Q4 Results Update
Hero Honda Q4 Results UpdateAngel Broking
 
Bajaj auto Result Updated
Bajaj auto Result UpdatedBajaj auto Result Updated
Bajaj auto Result UpdatedAngel Broking
 
How 2010 Marks The Beginning
How 2010 Marks The BeginningHow 2010 Marks The Beginning
How 2010 Marks The BeginningFranchiseExpo.in
 
Billerud Interim Report Q2 2012 presentation
Billerud Interim Report Q2 2012 presentationBillerud Interim Report Q2 2012 presentation
Billerud Interim Report Q2 2012 presentationBillerudKorsnäs
 
general mills AR2005
general mills  AR2005general mills  AR2005
general mills AR2005finance22
 

Tendances (18)

GSK con ru1 qcy2010-230410
GSK con ru1 qcy2010-230410GSK con ru1 qcy2010-230410
GSK con ru1 qcy2010-230410
 
GSKCH
GSKCHGSKCH
GSKCH
 
BHEL -Result Update
BHEL -Result UpdateBHEL -Result Update
BHEL -Result Update
 
KF in brief 2004
KF in brief 2004KF in brief 2004
KF in brief 2004
 
UPL
UPLUPL
UPL
 
Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference
 
Billerud Interim Report Q1 2012 presentation
Billerud Interim Report Q1 2012 presentationBillerud Interim Report Q1 2012 presentation
Billerud Interim Report Q1 2012 presentation
 
Britvic company evaluation
Britvic company evaluationBritvic company evaluation
Britvic company evaluation
 
Aventis Result Update
Aventis Result UpdateAventis Result Update
Aventis Result Update
 
Alembic
Alembic Alembic
Alembic
 
BASF Capital Market Story 05/2012
BASF Capital Market Story  05/2012BASF Capital Market Story  05/2012
BASF Capital Market Story 05/2012
 
Hero Honda Q4 Results Update
Hero Honda Q4 Results UpdateHero Honda Q4 Results Update
Hero Honda Q4 Results Update
 
Bajaj auto Result Updated
Bajaj auto Result UpdatedBajaj auto Result Updated
Bajaj auto Result Updated
 
How 2010 Marks The Beginning
How 2010 Marks The BeginningHow 2010 Marks The Beginning
How 2010 Marks The Beginning
 
Billerud Interim Report Q2 2012 presentation
Billerud Interim Report Q2 2012 presentationBillerud Interim Report Q2 2012 presentation
Billerud Interim Report Q2 2012 presentation
 
Mahindra & Mahindra
Mahindra & MahindraMahindra & Mahindra
Mahindra & Mahindra
 
Zeus: home of the heavies
Zeus: home of the heaviesZeus: home of the heavies
Zeus: home of the heavies
 
general mills AR2005
general mills  AR2005general mills  AR2005
general mills AR2005
 

Similaire à Q4 2012 wessanen presentation

Wessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationWessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationKlaus Arntz
 
Wessanen agm 16 april 2013 en final
Wessanen agm 16 april 2013 en finalWessanen agm 16 april 2013 en final
Wessanen agm 16 april 2013 en finalKlaus Arntz
 
Wessanen q3 2012 press release
Wessanen q3 2012 press releaseWessanen q3 2012 press release
Wessanen q3 2012 press releaseKlaus Arntz
 
Wessanen Q3 2011 analyst&investors Kepler
Wessanen Q3 2011 analyst&investors KeplerWessanen Q3 2011 analyst&investors Kepler
Wessanen Q3 2011 analyst&investors KeplerKlaus Arntz
 
Wessanen Factsheet july 2012
Wessanen Factsheet july 2012Wessanen Factsheet july 2012
Wessanen Factsheet july 2012Klaus Arntz
 
BASF capital market story 10/2012
BASF capital market story 10/2012BASF capital market story 10/2012
BASF capital market story 10/2012BASF
 
Wessanen Factsheet Oct 2012
Wessanen Factsheet Oct 2012Wessanen Factsheet Oct 2012
Wessanen Factsheet Oct 2012Klaus Arntz
 
Q3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationQ3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationAkzoNobel
 
Resultados 2t12 v11 - inglês
Resultados 2t12   v11 - inglêsResultados 2t12   v11 - inglês
Resultados 2t12 v11 - inglêsvigor_ri
 
Resultados 2 q12 final - inglês
Resultados 2 q12   final - inglêsResultados 2 q12   final - inglês
Resultados 2 q12 final - inglêsvigor_ri
 
FY10 financial results
FY10 financial resultsFY10 financial results
FY10 financial resultsdarren_s
 
Balda GB 2011 englisch
Balda GB 2011 englischBalda GB 2011 englisch
Balda GB 2011 englischBalda AG
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&Afinance21
 
Stora Enso Interim Review Q2 2012
Stora Enso Interim Review Q2 2012Stora Enso Interim Review Q2 2012
Stora Enso Interim Review Q2 2012Stora Enso
 
Wessanen Q4 11 roadshow presentation
Wessanen Q4 11 roadshow presentationWessanen Q4 11 roadshow presentation
Wessanen Q4 11 roadshow presentationKlaus Arntz
 
Deutsche EuroShop Interim Report 9M 2012
Deutsche EuroShop Interim Report 9M 2012Deutsche EuroShop Interim Report 9M 2012
Deutsche EuroShop Interim Report 9M 2012Deutsche EuroShop AG
 
CONAGRA 2008 AR
CONAGRA 2008 ARCONAGRA 2008 AR
CONAGRA 2008 ARfinance21
 

Similaire à Q4 2012 wessanen presentation (20)

Wessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationWessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentation
 
Wessanen agm 16 april 2013 en final
Wessanen agm 16 april 2013 en finalWessanen agm 16 april 2013 en final
Wessanen agm 16 april 2013 en final
 
Resultados bayer
Resultados bayerResultados bayer
Resultados bayer
 
Wessanen q3 2012 press release
Wessanen q3 2012 press releaseWessanen q3 2012 press release
Wessanen q3 2012 press release
 
Wessanen Q3 2011 analyst&investors Kepler
Wessanen Q3 2011 analyst&investors KeplerWessanen Q3 2011 analyst&investors Kepler
Wessanen Q3 2011 analyst&investors Kepler
 
Wessanen Factsheet july 2012
Wessanen Factsheet july 2012Wessanen Factsheet july 2012
Wessanen Factsheet july 2012
 
BASF capital market story 10/2012
BASF capital market story 10/2012BASF capital market story 10/2012
BASF capital market story 10/2012
 
Wessanen Factsheet Oct 2012
Wessanen Factsheet Oct 2012Wessanen Factsheet Oct 2012
Wessanen Factsheet Oct 2012
 
Q3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationQ3 2012 Results Investor Presentation
Q3 2012 Results Investor Presentation
 
Resultados 2t12 v11 - inglês
Resultados 2t12   v11 - inglêsResultados 2t12   v11 - inglês
Resultados 2t12 v11 - inglês
 
Resultados 2 q12 final - inglês
Resultados 2 q12   final - inglêsResultados 2 q12   final - inglês
Resultados 2 q12 final - inglês
 
FY10 financial results
FY10 financial resultsFY10 financial results
FY10 financial results
 
Presentation sca year-end report 2012
Presentation sca year-end report 2012Presentation sca year-end report 2012
Presentation sca year-end report 2012
 
Dt results q1_2012
Dt results q1_2012Dt results q1_2012
Dt results q1_2012
 
Balda GB 2011 englisch
Balda GB 2011 englischBalda GB 2011 englisch
Balda GB 2011 englisch
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&A
 
Stora Enso Interim Review Q2 2012
Stora Enso Interim Review Q2 2012Stora Enso Interim Review Q2 2012
Stora Enso Interim Review Q2 2012
 
Wessanen Q4 11 roadshow presentation
Wessanen Q4 11 roadshow presentationWessanen Q4 11 roadshow presentation
Wessanen Q4 11 roadshow presentation
 
Deutsche EuroShop Interim Report 9M 2012
Deutsche EuroShop Interim Report 9M 2012Deutsche EuroShop Interim Report 9M 2012
Deutsche EuroShop Interim Report 9M 2012
 
CONAGRA 2008 AR
CONAGRA 2008 ARCONAGRA 2008 AR
CONAGRA 2008 AR
 

Plus de Klaus Arntz

Hfd 26mei2016 accountantsbolwerk vertoont scheuren
Hfd 26mei2016 accountantsbolwerk vertoont scheurenHfd 26mei2016 accountantsbolwerk vertoont scheuren
Hfd 26mei2016 accountantsbolwerk vertoont scheurenKlaus Arntz
 
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatie
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatieHfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatie
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatieKlaus Arntz
 
Wessanen H1 and Q2 2015 results
Wessanen H1 and Q2 2015 resultsWessanen H1 and Q2 2015 results
Wessanen H1 and Q2 2015 resultsKlaus Arntz
 
Wessanen q4 and fy 2014 results presentation
Wessanen q4 and fy 2014 results presentationWessanen q4 and fy 2014 results presentation
Wessanen q4 and fy 2014 results presentationKlaus Arntz
 
Wessanen q3 2014 trading update
Wessanen q3 2014 trading updateWessanen q3 2014 trading update
Wessanen q3 2014 trading updateKlaus Arntz
 
Wessanen roadshow Paris 1 July 2014
Wessanen roadshow Paris 1 July 2014Wessanen roadshow Paris 1 July 2014
Wessanen roadshow Paris 1 July 2014Klaus Arntz
 
Wessanen q1 2014 analyst&investor meeting 25 april
Wessanen q1 2014 analyst&investor meeting 25 aprilWessanen q1 2014 analyst&investor meeting 25 april
Wessanen q1 2014 analyst&investor meeting 25 aprilKlaus Arntz
 
Wessanen q4 2013 analyst&investor meeting 21 feb
Wessanen q4 2013 analyst&investor meeting 21 febWessanen q4 2013 analyst&investor meeting 21 feb
Wessanen q4 2013 analyst&investor meeting 21 febKlaus Arntz
 
Wessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateWessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateKlaus Arntz
 
Wessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateWessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateKlaus Arntz
 
Wessanen ppt at ing benelux conf sept2013
Wessanen ppt at ing benelux conf sept2013Wessanen ppt at ing benelux conf sept2013
Wessanen ppt at ing benelux conf sept2013Klaus Arntz
 
Q2 2013 wessanen analyst&investor meeting
Q2 2013 wessanen analyst&investor meetingQ2 2013 wessanen analyst&investor meeting
Q2 2013 wessanen analyst&investor meetingKlaus Arntz
 
Wessanen ppt at Rabobank food&agri conference London 28June
Wessanen ppt at Rabobank food&agri conference London 28JuneWessanen ppt at Rabobank food&agri conference London 28June
Wessanen ppt at Rabobank food&agri conference London 28JuneKlaus Arntz
 
Wessanen Q1 2013 roadshow ppt
Wessanen Q1 2013 roadshow pptWessanen Q1 2013 roadshow ppt
Wessanen Q1 2013 roadshow pptKlaus Arntz
 
Wessanen 21 nov2012 delft course light
Wessanen 21 nov2012 delft course lightWessanen 21 nov2012 delft course light
Wessanen 21 nov2012 delft course lightKlaus Arntz
 
Wessanen overview ppt sept2012
Wessanen overview ppt sept2012Wessanen overview ppt sept2012
Wessanen overview ppt sept2012Klaus Arntz
 
Wessanen Q2 2012 sustainability
Wessanen Q2 2012 sustainabilityWessanen Q2 2012 sustainability
Wessanen Q2 2012 sustainabilityKlaus Arntz
 
Wessanen Q2 2012 analyst&investors
Wessanen Q2 2012 analyst&investorsWessanen Q2 2012 analyst&investors
Wessanen Q2 2012 analyst&investorsKlaus Arntz
 
Rabobank Consumer Staples Conference Milan June2012
Rabobank Consumer Staples Conference Milan June2012Rabobank Consumer Staples Conference Milan June2012
Rabobank Consumer Staples Conference Milan June2012Klaus Arntz
 
Clipper tea March 2012
Clipper tea March 2012Clipper tea March 2012
Clipper tea March 2012Klaus Arntz
 

Plus de Klaus Arntz (20)

Hfd 26mei2016 accountantsbolwerk vertoont scheuren
Hfd 26mei2016 accountantsbolwerk vertoont scheurenHfd 26mei2016 accountantsbolwerk vertoont scheuren
Hfd 26mei2016 accountantsbolwerk vertoont scheuren
 
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatie
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatieHfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatie
Hfd 26mei2016 accountants verzetten zich tegen koers beroepsorganisatie
 
Wessanen H1 and Q2 2015 results
Wessanen H1 and Q2 2015 resultsWessanen H1 and Q2 2015 results
Wessanen H1 and Q2 2015 results
 
Wessanen q4 and fy 2014 results presentation
Wessanen q4 and fy 2014 results presentationWessanen q4 and fy 2014 results presentation
Wessanen q4 and fy 2014 results presentation
 
Wessanen q3 2014 trading update
Wessanen q3 2014 trading updateWessanen q3 2014 trading update
Wessanen q3 2014 trading update
 
Wessanen roadshow Paris 1 July 2014
Wessanen roadshow Paris 1 July 2014Wessanen roadshow Paris 1 July 2014
Wessanen roadshow Paris 1 July 2014
 
Wessanen q1 2014 analyst&investor meeting 25 april
Wessanen q1 2014 analyst&investor meeting 25 aprilWessanen q1 2014 analyst&investor meeting 25 april
Wessanen q1 2014 analyst&investor meeting 25 april
 
Wessanen q4 2013 analyst&investor meeting 21 feb
Wessanen q4 2013 analyst&investor meeting 21 febWessanen q4 2013 analyst&investor meeting 21 feb
Wessanen q4 2013 analyst&investor meeting 21 feb
 
Wessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateWessanen Q3 2013 trading update
Wessanen Q3 2013 trading update
 
Wessanen Q3 2013 trading update
Wessanen Q3 2013 trading updateWessanen Q3 2013 trading update
Wessanen Q3 2013 trading update
 
Wessanen ppt at ing benelux conf sept2013
Wessanen ppt at ing benelux conf sept2013Wessanen ppt at ing benelux conf sept2013
Wessanen ppt at ing benelux conf sept2013
 
Q2 2013 wessanen analyst&investor meeting
Q2 2013 wessanen analyst&investor meetingQ2 2013 wessanen analyst&investor meeting
Q2 2013 wessanen analyst&investor meeting
 
Wessanen ppt at Rabobank food&agri conference London 28June
Wessanen ppt at Rabobank food&agri conference London 28JuneWessanen ppt at Rabobank food&agri conference London 28June
Wessanen ppt at Rabobank food&agri conference London 28June
 
Wessanen Q1 2013 roadshow ppt
Wessanen Q1 2013 roadshow pptWessanen Q1 2013 roadshow ppt
Wessanen Q1 2013 roadshow ppt
 
Wessanen 21 nov2012 delft course light
Wessanen 21 nov2012 delft course lightWessanen 21 nov2012 delft course light
Wessanen 21 nov2012 delft course light
 
Wessanen overview ppt sept2012
Wessanen overview ppt sept2012Wessanen overview ppt sept2012
Wessanen overview ppt sept2012
 
Wessanen Q2 2012 sustainability
Wessanen Q2 2012 sustainabilityWessanen Q2 2012 sustainability
Wessanen Q2 2012 sustainability
 
Wessanen Q2 2012 analyst&investors
Wessanen Q2 2012 analyst&investorsWessanen Q2 2012 analyst&investors
Wessanen Q2 2012 analyst&investors
 
Rabobank Consumer Staples Conference Milan June2012
Rabobank Consumer Staples Conference Milan June2012Rabobank Consumer Staples Conference Milan June2012
Rabobank Consumer Staples Conference Milan June2012
 
Clipper tea March 2012
Clipper tea March 2012Clipper tea March 2012
Clipper tea March 2012
 

Dernier

the 25 most beautiful words for a loving and lasting relationship.pdf
the 25 most beautiful words for a loving and lasting relationship.pdfthe 25 most beautiful words for a loving and lasting relationship.pdf
the 25 most beautiful words for a loving and lasting relationship.pdfFrancenel
 
Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Probe Gold
 
Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024CollectiveMining1
 
Mandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalayResources
 
Corporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfCorporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfProbe Gold
 
slideshare_2404_presentation materials_en.pdf
slideshare_2404_presentation materials_en.pdfslideshare_2404_presentation materials_en.pdf
slideshare_2404_presentation materials_en.pdfsansanir
 
Q1 Quarterly Update - April 16, 2024.pdf
Q1 Quarterly Update - April 16, 2024.pdfQ1 Quarterly Update - April 16, 2024.pdf
Q1 Quarterly Update - April 16, 2024.pdfProbe Gold
 
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd
 
Corporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfCorporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfProbe Gold
 
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024CollectiveMining1
 
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...USDAReapgrants.com
 

Dernier (12)

the 25 most beautiful words for a loving and lasting relationship.pdf
the 25 most beautiful words for a loving and lasting relationship.pdfthe 25 most beautiful words for a loving and lasting relationship.pdf
the 25 most beautiful words for a loving and lasting relationship.pdf
 
Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024
 
Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024
 
Mandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR Presentation
 
Corporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfCorporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdf
 
slideshare_2404_presentation materials_en.pdf
slideshare_2404_presentation materials_en.pdfslideshare_2404_presentation materials_en.pdf
slideshare_2404_presentation materials_en.pdf
 
Q1 Quarterly Update - April 16, 2024.pdf
Q1 Quarterly Update - April 16, 2024.pdfQ1 Quarterly Update - April 16, 2024.pdf
Q1 Quarterly Update - April 16, 2024.pdf
 
Korea District Heating Corporation 071320 Algorithm Investment Report
Korea District Heating Corporation 071320 Algorithm Investment ReportKorea District Heating Corporation 071320 Algorithm Investment Report
Korea District Heating Corporation 071320 Algorithm Investment Report
 
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
 
Corporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdfCorporate Presentation Probe April 2024.pdf
Corporate Presentation Probe April 2024.pdf
 
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024
 
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...
Leveraging USDA Rural Development Grants for Community Growth and Sustainabil...
 

Q4 2012 wessanen presentation

  • 1. Wessanen 2012 overview Revenue EBIT before exceptionals 129 6,3 273 €711mln 1,8 €19mln* 113 0,0 22,0 * 205 Grocery HFS IZICO ABC Grocery HFS IZICO ABC * Incl. intercompany sales * Incl. non-allocated FTEs (average) Average Capital Employed 62 7 434 451 48 89 2,064 €240mln 37 487 630 59 Grocery HFS IZICO ABC Corporate 1 Grocery HFS IZICO ABC Corporate
  • 2. Royal Wessanen nv Q4/FY 2012 Amsterdam, 22 February 2013 www.wessanen.com
  • 3. FY 2012: a challenging year 730 Revenue (in € mln) The economy and market A turbulent year for the global economy Organic market trending positively 720 Our positives Grocery continues to perform well 710 Acquisition of Clipper Teas Creation of one frozen food company 0.7% Strengthening Supervisory Board 700 2011 Price/mix Volume Currency Acq/divest. 2012 Our negatives Performance HFS disappointing ♦ Autonomous third party revenue growth Postponement sale of ABC EBIT (in € mln) Sizeable goodwill impairments Our remedy 23,7 18,8 Initiated a broad restructuring to build a more European -19,0 integrated marketing-led company -45,8 2011 2012 ♦ Reported, ♦ Normalised 3
  • 4. Grocery  Showing a good performance all throughout the year In € mln Q4-12 Q4-11  Realised 4.6% autonomous growth in 2012 Revenue 68.9 58.7  6.9% in the fourth quarter Autonomous growth 6.9%  Core brands growing such as Bjorg, Zonnatura and Whole Earth Normalised EBIT 6.3 1.9  Six out of eight core categories growing Impairments (15.8) (3.0) Other exceptionals (3.5) (0.5)  Clipper Teas acquired, UK market leader in organic and fair trade teas EBIT (13.0) (1.6)  11% growth in 2012  In France introduced early 2013  Netherlands to follow next few months In € mln FY12 FY11 Revenue 272.8 243.9  Innovation examples:  Bjorg muesli superfruits; coconut milk cooking aid; fourré Autonomous growth 4.6% chocolat with hazelnut Normalised EBIT 22.0 18.0  Zonnatura loose green tea; squeeze fruit/vegetables  Kallo gravy granules Impairments (15.8) (3.0) Other exceptionals (4.7) 0.6 EBIT 1.5 15.6 4
  • 5. Health Food Stores (HFS)  HFS showing a disappointing performance in all three businesses In € mln Q4-12 Q4-11  France impacted by changing health food stores landscape Revenue 50.9 53.3  Rise of chains at expense independent stores  Lower sales, especially in wholesale and at fresh Autonomous growth (4.5)% Normalised EBIT 0.8 1.3  Benelux impacted by lost customers and weak performance at Fresh  Existing Natuurwinkel and independent stores growing Impairments (23.9) (19.8) Other exceptionals (6.5) (1.0)  Germany impacted by weak brand performance Allos and declining revenues at Reformhaus channel (Tartex) EBIT (29.6) (19.5)  Innovation examples:  Tartex pasta sauces; jubilee yeast pastries In € mln FY12 FY11  Allos crunchy (e.g. almond and cinnamon); muesli (e.g. Revenue 204.8 247.5 cranberry-Goji) Autonomous growth (5.0)% Normalised EBIT - 5.0 Impairments (23.9) (23.1) Other exceptionals (6.5) (3.7) EBIT (30.4) (21.8) 5
  • 6. IZICO - integrated frozen foods company  Acquiring non-controlling stake Favory paved the way for creation one integrated company In € mln Q4-12 Q4-11 Revenue 29.0 29.1  New management team in place Autonomous growth (0.1)%  New name IZICO Normalised EBIT 0.7 0.2  easy (IZI), go (CO), ice (IZ) and company (CO) Impairments (7.0) (14.3)  Milestone plan being executed for full alignment and process Other exceptionals (6.2) (0.3) integration Beckers Benelux and Favory EBIT (12.5) (14.4)  Combining both headquarters in Breda  Integration marketing & sales, operations, finance and HR In € mln FY12 FY11  Closure Favory Deurne plant as of the end of March Revenue 112.5 113.1 Autonomous growth (0.5)% Normalised EBIT 1.8 2.3 Impairments (7.0) (14.3) Other exceptionals (6.2) (0.3) EBIT (11.4) (12.3) 6
  • 7. ABC - market leader RTD frozen pouches  Capitalising on further optimisation in 2011 after significant In € mln Q4-12 Q4-11 improvement multiple processes in previous years Revenue 16.9 18.0  Strong step-up in marketing spending in $-terms  Supporting key seasonal holidays Autonomous growth (4.7)%  First-ever national TV advertising campaign Normalised EBIT (3.0) (0.5)  Broad range traditional and digital media Impairments - 0.1  Daily’s modest decline in growing RTD market Other exceptionals - 0.1  More competition emerged in frozen pouch segment  Remained clear market leader (market share; household EBIT (3.0) (0.3) penetration; repeat purchases)  Innovations such as light and season-extending RTD pouches In € mln FY12 FY11 Revenue 128.6 112.6  Little Hug double digits revenue growth  Especially 20-pack and 40-pack performing well Autonomous growth 5.7%  Multi-year revitalisation process increasingly paying off Normalised EBIT 6.3 9.9 Impairments (0.1) 0.8 Other exceptionals 0.1 0.4 EBIT 6.3 11.1 7
  • 8. ABC (cont’d)  Why postponement divestment ?!  Bids not adequately reflecting fundamental value • Uncertainties attached to relatively short track record in emerging RTD frozen pouch category; perceived to be crowded competitive field  Realise better value for our shareholders at a later stage  The process  Process kicked off in June  Conducted a comprehensive process  Good level of interest from strategic and financial parties  Next steps  Reported as ‘continuing operations’  Clear plans / budgets in place  Labelled non-core 8
  • 9. ‘Wessanen 2015’  Announced late November 2012  Consultation with European and local works councils have been / are taking place  Wessanen will become a more consumer- and customer-led company  To deliver more efficiently our strategic agenda and to adapt to the changed magnitude and circumstances of the business  We have been initiating wide range of actions  To increase focus  To substantially reduce complexity  To become more profitable by reducing costs  Detailed plan and timeline with numerous actions at our various businesses  Progress (including savings and staff reduction) closely monitored  Executing plans in various ‘waves’, to reduce executional risks 9
  • 10. ‘Wessanen 2015’ - the numbers  Reduction of approx. 300 FTE of which 250 forced redundancies  Grocery/HFS/Corporate ± 190FTE  IZICO ± 110 FTE  Expected one-off costs  €(21) mln cash, largely accounted for in Q4, remainder in 2013  €(7.0) mln non-cash due to impairment Deurne plant  Expected savings €15mln p.a. from 2014 onwards  €10 mln at Grocery/HFS/Corporate  € 5mln at IZICO  Includes lower employee / other operating expenses  Excludes any expected benefits to top-line 10
  • 11. ‘Wessanen 2015’ - a wide range of actions  Create more focus on our activities  Further increased focus on core brands and eight core categories  Expansion number of CBTs (category brand teams)  Benelux operations split in branded and distribution  French HFS operations split in branded and distribution  Integration De Rit in Germany operations  Reduce complexity / simplify processes  Cutting the tail / reducing number of SKUs at • Dutch brands • French HFS brands; exiting frozen range at Bonneterre • Export  Centralising quality department  Focus on one franchise formula (Natuurwinkel), to end GooodyFooods formula  Supply chain to manage our plants as of 2013  Streamlining supply chain processes  Addressing low-yielding and non-performing activities  Strongly reducing German grocery presence, changing go-to-market approach  Focus Italian grocery on non-dairy (soy) 11
  • 12. Ronald Merckx (CFO) • Q4/FY financials 12
  • 13. Q4/FY key figures In € million Q4-12 Q4-11 FY-12 FY-11 Revenue 163.8 157.2 710.8 706.0 Autonomous growth 0.7% 0.7% Gross contribution 60.9 60.5 270.5 263.6 As % of revenue 37.2% 38.5% 38.1% 37.3% Normalised EBIT 1.9 (1.3) 18.8 23.7 As % of revenue 1.1% (0.8)% 2.6% 3.4% EBIT (61.6) (39.9) (45.8) (19.0) Net result ¹ (61.5) (35.1) (53.2) (17.1) Earnings per share (EPS) (0.81) (0.46) (0.70) (0.23) 13 ¹ Attributable to Wessanen equity holders
  • 14. EBIT - from normalised to reported Q4-12 Q4-11 FY-12 FY-11 Normalised EBIT 1.9 (1.3) 18.8 23.7 Impairments (46.7) (37.0) (46.8) (39.6) Wessanen 2015 (16.3) - (16.6) - Other exceptional costs (0.5) (1.6) (1.2) (3.1) EBIT (61.6) (39.9) (45.8) (19.0) 14
  • 15. Impairments of goodwill and PPE  Grocery UK - Kallo €(15.8) mln  Lower growth projections dairy alternatives, loss private label contract, adverse movement pre-tax discount rate (12.1%→12.7%)  HFS - Tartex €(19.9) mln  Lower growth projections Reformhaus channel  Private label business negatively impacted by insolvency one of our customers  HFS - Allos €(3.5) mln  Lower growth projections 2 core categories  Difficulties in passing on increased raw material costs  HFS - France €(0.5) mln *  Weaker market outlook  IZICO €(7.0) mln  Closure of Favory Deurne plant in March 2013 * €(0.3) mln relates to goodwill and €(0.2) mln relates to other intangibles 15
  • 16. Year end carrying value goodwill/brands In € mln Goodwill Brands Total Grocery - France 10.4 9.1 19.5 Grocery - UK (Kallo / Clipper) 11.1 10.5 21.6 Grocery - Benelux 4.6 - 4.6 HFS - Allos 9.3 2.1 11.4 HFS - Tartex - 1.2 1.2 Carrying value year end 2012 35.4 22.9 58.3 At year end 2012: no carrying value of goodwill and/or brands at Grocery Italy, Grocery Germany, HFS France, HFS Benelux, IZICO and ABC 16
  • 17. Cash flow 2012 22.2 (42.3) Increase working (7.6) capital Cash flow from 22.2 earnings (26.1) Sources Net Investments (*) Increase 20.1 of net debt (**) (6.1) Dividends paid (2.5) Derivatives and FX Uses 17
  • 18. Net debt / Leverage ratio In € mln 100 Net debt 75 €55 mln 50 25 0 Q4 10 Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 3 Leverage ratio 1.7x 2 1 0 Q4 10 Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 18
  • 19. Piet Hein Merckens (CEO) • Closing remarks 19
  • 20. Looking forward  2012 was a turbulent year for the global economy  Organic food markets continue to trend positively  We have made clear progress in numerous areas, however not all initiatives have resulted in desired outcome  We have run a connected leadership development programme for our top-60  We have initiated a comprehensive transformation programme  As of 2014 €15 mln of savings p.a.  All the right actions, full of confidence these will bear fruit  2013 will be another challenging year: “Store is open while we are renovating and innovating” 20
  • 22. Bridge - revenue growth 2012 In € mln 730 (2.1).% 2.8% 1.8% (4.2)% (0.2)% 2.6% 0.7% 720 710 700 690 Autonomous revenue growth 680 0.7% 670 ts ix e r r cy 1 2 e pe m n 1 1 /m th en e 0 0 u p tm 2 2 O ol li ce rr C V es u ri C P iv D 22
  • 23. Bridge: EBITE → EBIT In € mln 30 20 10 €(46.8) €(45.8) 0 ts s E e y O C FS 1 2 al IT t r en B 01 01 IC ra ce on H A EB IZ rm po 2 2 -10 ro ti or G p ai ce p C Im Ex -20 €23.7 €4.0 €(5.0) €(0.5) €(3.6) €0.2 €18.8 €(17.8) -30 -40 -50 23
  • 24. Working capital 80 4 quarter average working capital 60 40 20 0 Q4 08 Q2 09 Q4 09 Q2 10 Q4 10 Q2 11 Q4 11 Q2 12 Q4 12 40 q-on-q movement working capital 20 0 -20 -40 Q4 08 Q2 09 Q4 09 Q2 10 Q4 10 Q2 11 Q4 11 Q2 12 Q4 12 24
  • 25. Cash flow Q4 2012 3.7 (2.1) Decrease working 1.6 (1.6) Net Investments capital Derivatives and (0.5) FX 2.1 Decrease (1.6) of net Cash flow debt from earnings Sources Uses 25
  • 26. A very sound financial position In € mln Dec 12 Dec 11 In € mln Dec12 Dec11 Assets Liabilities Property, plant and equipment 77.4 86.4 Total equity 101.6 166.1 Intangible assets 66.8 90.6 Interest-bearing loans 60.7 37.4 Investment associates/other 1.1 1.0 Employee benefits 24.1 24.0 Deferred tax assets 9.2 8.8 Provisions / Deferred tax liabilities 5.4 3.9 Non-current assets 154.5 186.8 Non-current liabilities 90.2 65.3 Bank overdrafts / current debt 1.4 2.9 Inventories 72.3 67.5 Interest-bearing loans/borrowings 2.5 0.1 Income tax receivables - 2.2 Provisions 16.8 3.3 Trade receivables 85.7 78.9 Income tax payables 0.7 0.5 Other receivables / prepayments 15.7 24.4 Trade payables 68.3 70.5 Cash (equivalents) 9.7 8.2 Non-trade payables/accrued expenses 56.4 59.3 Current assets 183.4 181.2 Current liabilities 146.1 136.6 TOTAL ASSETS 337.9 368.0 TOTAL EQUITY & LIABILITIES 337.9 368.0 26
  • 27. Financials Q4/FY - guidance 2013 Financials Q4  Net financing costs €(1.1) mln Q4-11: €(0.9) mln  Income tax expenses €1.2 mln Q4-11: €1.7 mln  Capex €(1.2) mln Q4-11: €(3.3) mln Financials Full Year  Net financing costs €(3.8) mln FY-11: €(3.5) mln  Income tax expenses €(3.9) mln FY-11: €1.5 mln  Capex €(5.7) mln FY-11: €(10.2) mln Guidance 2013  Net financing costs €(3)-(4) mln  Effective tax rate around 35%  Capex €(8)-(10) mln  Depreciation and amortisation €(14) mln  Non-allocated expenses (incl. corporate) €(11) mln 27
  • 28. Royal Wessanen nv Q4 2011 Amsterdam, 23 February 2012

Notes de l'éditeur

  1. Mar 6, 2013 Wessanen overview